4KHR image
Entry Detail
PDB ID:
4KHR
Title:
HCV NS5B GT1A C316Y with GSK5852
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2013-05-01
Release Date:
2013-05-29
Method Details:
Experimental Method:
Resolution:
2.45 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:NS5B RNA-dependent RNA polymerase
Mutations:F101Y, C110S, R113S, K114R, C316Y
Chain IDs:A, B
Chain Length:579
Number of Molecules:2
Biological Source:Hepatitis C virus subtype 1a
Primary Citation

Abstact

A boronic acid moiety was found to be a critical pharmacophore for enhanced in vitro potency against wild-type hepatitis C replicons and known clinical polymorphic and resistant HCV mutant replicons. The synthesis, optimization, and structure-activity relationships associated with inhibition of HCV replication in a subgenomic replication system for a series of non-nucleoside boron-containing HCV RNA-dependent RNA polymerase (NS5B) inhibitors are described. A summary of the discovery of 3 (GSK5852), a molecule which entered clinical trials in subjects infected with HCV in 2011, is included.

Legend

Protein

Chemical

Disease

Primary Citation of related structures